Literature DB >> 29352705

The long road towards a safe and effective treatment of chronic Chagas disease.

Julio A Urbina1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29352705     DOI： 10.1016/S1473-3099(17)30535-2

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN： 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  8 in total

1.  Sterol 14α-Demethylase Structure-Based Optimization of Drug Candidates for Human Infections with the Protozoan Trypanosomatidae.

Authors:  Laura Friggeri; Tatiana Y Hargrove; Girish Rachakonda; Anna L Blobaum; Paxtyn Fisher; Gabriel Melo de Oliveira; Cristiane França da Silva; Maria de Nazaré C Soeiro; W David Nes; Craig W Lindsley; Fernando Villalta; F Peter Guengerich; Galina I Lepesheva
Journal:  J Med Chem       Date:  2018-11-30       Impact factor: 7.446

2.  The cytosolic tryparedoxin peroxidase from Trypanosoma cruzi induces a pro-inflammatory Th1 immune response in a peroxidatic cysteine-dependent manner.

Authors:  Lucía López; María Laura Chiribao; Magalí C Girard; Karina A Gómez; Paula Carasi; Marisa Fernandez; Yolanda Hernandez; Carlos Robello; Teresa Freire; María Dolores Piñeyro
Journal:  Immunology       Date:  2021-01-25       Impact factor: 7.397

3.  Administration of artinm lectin reduces the severity of the acute phase infection with Trypanosoma cruzi.

Authors:  Camila Botelho Miguel; Thiago Aparecido da Silva; Wellington Francisco Rodrigues; Patrícia Kellen Martins Oliveira-Brito; Maria Cristina Roque-Barreira; Javier Emílio Lazo-Chica
Journal:  FASEB Bioadv       Date:  2021-01-25

Review 4.  Advances in preclinical approaches to Chagas disease drug discovery.

Authors:  Fernando Villalta; Girish Rachakonda
Journal:  Expert Opin Drug Discov       Date:  2019-08-14       Impact factor: 6.098

5.  Combination With Tomatidine Improves the Potency of Posaconazole Against Trypanosoma cruzi.

Authors:  Marianne Rocha-Hasler; Gabriel Melo de Oliveira; Aline Nefertiti da Gama; Ludmila Ferreira de Almeida Fiuza; Anna Frieda Fesser; Monica Cal; Romina Rocchetti; Raiza Brandão Peres; Xue Li Guan; Marcel Kaiser; Maria de Nazaré Correia Soeiro; Pascal Mäser
Journal:  Front Cell Infect Microbiol       Date:  2021-03-04       Impact factor: 5.293

6.  Outcome of E1224-Benznidazole Combination Treatment for Infection with a Multidrug-Resistant Trypanosoma cruzi Strain in Mice.

Authors:  Lívia de Figueiredo Diniz; Ana Lia Mazzeti; Ivo Santana Caldas; Isabela Ribeiro; Maria Terezinha Bahia
Journal:  Antimicrob Agents Chemother       Date:  2018-05-25       Impact factor: 5.191

7.  Validation of Apolipoprotein A-1 and Fibronectin Fragments as Markers of Parasitological Cure for Congenital Chagas Disease in Children Treated With Benznidazole.

Authors:  Elizabeth Ruiz-Lancheros; Asieh Rasoolizadeh; Eric Chatelain; Facundo Garcia-Bournissen; Samanta Moroni; Guillermo Moscatelli; Jaime Altcheh; Momar Ndao
Journal:  Open Forum Infect Dis       Date:  2018-11-01       Impact factor: 3.835

8.  Rate-of-Kill (RoK) assays to triage large compound sets for Chagas disease drug discovery: Application to GSK Chagas Box.

Authors:  Juan Cantizani; Pablo Gamallo; Ignacio Cotillo; Raquel Alvarez-Velilla; Julio Martin
Journal:  PLoS Negl Trop Dis       Date:  2021-07-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.